Davita Clinical Research
Hepcidin–A Potential Novel Biomarker for Iron Status in Chronic Kidney Disease
  • Home >
  • About Us >
    • Leadership >
    • Careers >
      • Our Culture >
      • Diversity & Belonging >
    • Our History >
    • Awards and Recognition >
  • Services >
    • Late Phase Renal Research (ESKD) >
    • Alliance Site Network >
    • International Trials >
  • News >
    • Press Releases >
    • Events >
  • Resources >
    • Blog >
    • Video Library >
  • Contact Us >
    • For Sponsors >
    • For Investigators >
    • For Participants >
  • Home
  • About Us
    • Leadership
    • Careers
      • Our Culture
      • Diversity & Belonging
    • Our History
    • Awards and Recognition
  • Services
    • Late Phase Renal Research (ESKD)
    • Alliance Site Network
    • International Trials
  • News
    • Press Releases
    • Events
  • Resources
    • Blog
    • Video Library
  • Contact Us
    • For Sponsors
    • For Investigators
    • For Participants
  • Search this site

  • Home
  • Hepcidin–A Potential Novel Biomarker for Iron Status in Chronic Kidney Disease

Hepcidin–A Potential Novel Biomarker for Iron Status in Chronic Kidney Disease

Posted by:

Zaritsky J, Young B, Wang HJ, Westerman M, Olbina G, Nemeth E, Ganz T, Rivera S, Nissenson AR, Salusky IB.  Clin J Am Soc Nephrol. 2009;4(6):1051-6. Read more

Nocturnal Hemodialysis improves Hemoglobin Sensitivity to Erythropoietin Therapy

Posted by:

Francisco L, Lynn R, Gill T, Simon S, Volz A, Spach K, Levine R, Provenzano R. Nocturnal Hemodialysis Improves Hemoglobin Sensitivity to Erythropoietin Therapy. American Society of Nephrology Renal Week…. Read more

Improved Clinical Outcomes in Hemodialysis Patients Prescribed Cinacalcet Hydrochloride

Posted by:

Block G, Zaun D, Liu J, Smits G, Nieman K, Newsome B, Persky M, St. Peter W. Improved Clinical Outcomes in Hemodialysis Patients Prescribed Cinacalcet Hydrochloride. American Society of Nephrology… Read more

Reducing the Catheter Rate: Results from the DaVita / SCAN Health Plan Medicare Demonstration Project

Posted by:

Wang X, Nissenson A, Robertson J. Reducing the Catheter Rate: Results from the DaVita / SCAN Health Plan Medicare Demonstration Project. American Society of Nephrology Renal Week. San Diego, CA,… Read more

Serum Albumin and Phosphorus Control are Superior in Patients on Nocturnal, In-Center Nocturnal Hemodialysis Compared to Those on Conventional, In-Center Hemodialysis

Posted by:

Benner D, Provenzano R, Spach K, Krishnan M, Nissenson A. Serum Albumin and Phosphorus Control are Superior in Patients on Nocturnal, In-Center Nocturnal Hemodialysis. American Society of Nephrology Renal Week…. Read more

Comparison of Patient Mortality Among Four Dialysis Modalities

Posted by:

Nissenson A, Provenzano R, Showers M, Levine R. Comparison of Patient Mortality Among Four Dialysis Modalities. American Society of Nephrology Renal Week. San Diego, CA, Oct 27 – Nov 1,… Read more

Effects of IMPACT Program on Mortality among Incident Hemodialysis Patients

Posted by:

Robertson J, Goel P, Chen G, Levine R, Benner D, Burdan A. Effects of IMPACT Program on Mortality among Incident Hemodialysis Patients. American Society of Nephrology Renal Week. San Diego,… Read more

Effect of IMPACT Program on Clinical Indicators in Incident Hemodialysis Patients

Posted by:

Robertson J, Goel P, Chen G, Levine R, Benner D, Burdan A. Effect of IMPACT Program on Clinical Indicators in Incident Hemodialysis Patients. American Society of Nephrology Renal Week. San… Read more

Longitudinal Trends in Therapy of Mineral Metabolism in the US

Posted by:

Patel N, Isakova T, Weldon J, Nissenson A, Wolf M. Longitudinal Trends in Therapy of Mineral Metabolism in the US. American Society of Nephrology Renal Week. San Diego, CA, Oct… Read more

Potassium Intake and 5-Year Mortality in Maintenance Hemodialysis Patients

Posted by:

Noori N, Kopple J, Benner D, Kalantar-Zadeh K. Potassium Intake and 5-Year Mortality in Maintenance Hemodialysis Patients. American Society of Nephrology Renal Week. San Diego, CA, Oct 27 – Nov… Read more

Categories

  • Blog
  • Events
  • Press Releases
  • Video

Blog: A Guide to Different Models of SMOs

Navigate
  • Home
  • About Us
  • Services
  • News
  • Resources
  • Contact Us
Headquarters
DaVita Clinical Research®
6600 France Ave S Suite 660
Edina, MN 55435 (Map)
  • Telephone: 888-345-2567
  • Fax: 866-852-3241
Corporate
  • Careers
  • davita.com
  • mykidneyresearch.com
  • Renal Research FAQ
Follow us on:
  • LinkedIn
  • Twitter
  • YouTube
  • Facebook
  • © 2026 DaVita Inc.
  • Web privacy policy
  • Sitemap
  • Terms of use
x
x

View PDF